The Notch/Hes1 pathway sustains NF-κB activation through CYLD repression in T cell leukemia. - Wikidata - awgldk - TriplyDB

The Notch/Hes1 pathway sustains NF-κB activation through CYLD repression in T cell leukemia.

The Notch/Hes1 pathway sustains NF-κB activation through CYLD repression in T cell leukemia.

http://www.wikidata.org/entity/Q34235332

about

Role of Notch signaling in regulating innate immunity and inflammation in health and disease Recent advancements of bortezomib in acute lymphocytic leukemia treatment From fly wings to targeted cancer therapies: a centennial for notch signaling Proinflammatory signaling regulates hematopoietic stem cell emergence.Therapeutic targeting of the cyclin D3:CDK4/6 complex in T cell leukemia.Chemical metabolic inhibitors for the treatment of blood-borne cancers The tumour suppressor CYLD regulates the p53 DNA damage response New methods for separating causes from effects in genomics data.Augmented osteogenic responses in human aortic valve cells exposed to oxLDL and TLR4 agonist: a mechanistic role of Notch1 and NF-κB interaction Angiocrine factors deployed by tumor vascular niche induce B cell lymphoma invasiveness and chemoresistance Proteasome inhibitors exert cytotoxicity and increase chemosensitivity via transcriptional repression of Notch1 in T-cell acute lymphoblastic leukemia Premalignant PTEN-deficient thymocytes activate microRNAs miR-146a and miR-146b as a cellular defense against malignant transformation.Deubiquitinating enzymes as promising drug targets for infectious diseases.Pathogenetic importance and therapeutic implications of NF-κB in lymphoid malignancies.Activation of the Notch1 Stem Cell Signaling Pathway during Routine Cell Line Subculture.Role of notch signaling in the maintenance of human mesenchymal stem cells under hypoxic conditions.Hypoxia suppresses cylindromatosis (CYLD) expression to promote inflammation in glioblastoma: possible link to acquired resistance to anti-VEGF therapy.Inhibition of specific NF-κB activity contributes to the tumor suppressor function of 14-3-3σ in breast cancer.Contrasting roles of histone 3 lysine 27 demethylases in acute lymphoblastic leukaemia.Two clinical phenotypes in polycythemia vera.How microRNA and transcription factor co-regulatory networks affect osteosarcoma cell proliferation.Growth factor independent-1 maintains Notch1-dependent transcriptional programming of lymphoid precursors.NOTCH pathway inactivation promotes bladder cancer progression Metalloprotease-disintegrin ADAM12 expression is regulated by Notch signaling via microRNA-29.Apoptotic role of IKK in T-ALL therapeutic response.NF-κB and cancer: a paradigm of Yin-Yang.MicroRNA-500 sustains nuclear factor-κB activation and induces gastric cancer cell proliferation and resistance to apoptosis.mRNA expression levels and genetic status of genes involved in the EGFR and NF-κB pathways in metastatic non-small-cell lung cancer patients.CYLD Regulates Noscapine Activity in Acute Lymphoblastic Leukemia via a Microtubule-Dependent Mechanism.The role of Notch signaling in muscle progenitor cell depletion and the rapid onset of histopathology in muscular dystrophy.CYLD-mediated signaling and diseases.Crosstalk between the canonical NF-κB and Notch signaling pathways inhibits Pparγ expression and promotes pancreatic cancer progression in mice.Therapeutic targeting of HES1 transcriptional programs in T-ALL Novel Roles for Notch3 and Notch4 Receptors in Gene Expression and Susceptibility to Ozone-Induced Lung Inflammation in Mice Notch signaling sustains the expression of Mcl-1 and the activity of eIF4E to promote cell survival in CLL.Notch Signaling in Inflammation-Induced Preterm Labor.HES1 opposes a PTEN-dependent check on survival, differentiation, and proliferation of TCRβ-selected mouse thymocytes.Potential Therapeutic Role of Z-Isochaihulactone in Lung Cancer through Induction of Apoptosis via Notch Signaling.Inactivation of ribosomal protein L22 promotes transformation by induction of the stemness factor, Lin28B.Bortezomib enhances expression of effector molecules in anti-tumor CD8+ T lymphocytes by promoting Notch-nuclear factor-κB crosstalk.

P2860

Q26764946-72E95E61-1491-4FD9-A797-7EC6F8E185B7 Q26829613-B1C1204C-123F-4A2C-91D8-3D141028C341 Q27004534-573B5BBB-C69D-4A4E-B2DE-3016F30E3DFD Q27324011-C4D9D0A8-0E83-4770-AAEB-8D6016EC1B2E Q27851940-12D22B1F-0392-430A-86A7-72CF99E0C34D Q28822335-A9C2D52D-D021-4972-BC58-24ACFB1AB541 Q28828272-632272DB-00F7-4E08-9A49-6980007B750E Q30531261-0EF22C95-5D7B-4AC5-BD97-27139AE44D2B Q33583872-50B9FAA4-83CA-4BA0-85D9-CC867D49DC49 Q33598375-C24F9CEC-7A6B-4271-9EB6-4003B22DBCDF Q33732419-5C354767-7C35-43CC-9EFA-EB26B2EFED99 Q33814453-3C9D4474-1E61-4729-926A-850D2CD75648 Q33836097-9A5583B5-22E6-43E2-945C-2C4F686F71CA Q33889168-71C6F92F-AEDB-4BDA-9C04-9770A96F2124 Q34009814-87A4A5C2-902D-4373-B90D-00F64F861BB2 Q34138039-5D536FB9-D436-4DDD-8FB5-B0E405CB5775 Q34227712-A46623A0-B50A-42C1-88A0-96FEDD7359CE Q34295493-B7B68A06-F660-4131-A71F-CCA3A6F9FD8B Q34403179-7F807FDF-98EF-4093-9CC1-A92F014CE13F Q34415448-1E683CC3-7BCB-4D07-8FF5-663A62124D7B Q34979339-89D910AA-2C19-4BA2-B926-92B2ED337FE4 Q34998268-B0BAE0E7-4B45-4BF4-9474-BE79E5E0301D Q35056671-5FC8065C-66E5-4D8C-8F16-34387EBE13B9 Q35065212-A190B0B2-E0FC-4147-96C7-6DD3C5DEFAF0 Q35169062-4BA40FFF-39F5-4D18-9E12-F8012691B325 Q35232248-C549E400-355F-457A-AEC6-F9BBC7535D3C Q35273755-CE9BF5C2-4EDF-4407-9380-AA741AA3C217 Q35471961-AEDCB880-EA56-4289-A511-0AD3EF6F4FBC Q35475874-D52167E0-D471-493E-BAB6-DC2EBF2A3415 Q35524598-6F27F253-58DC-446E-A947-75CC2D2CB532 Q35565726-DA2F49E7-A890-4DD1-9EC4-497290A90163 Q35578568-9D7BCB74-CAF1-43A3-9C1F-004A3338052B Q35584248-63E42595-D918-44E9-84DB-26401EB46854 Q35928020-349A54B1-01D0-4209-AEA1-0BF54961CC6B Q36140862-3B02CF57-050D-4646-B59B-0735774EB50D Q36168410-5207E41D-9F2D-4824-B0EB-F6E0902F6CCB Q36177924-6CCE9043-689F-4FF4-8538-CD3EE8B9C234 Q36291949-07DF7CB0-9244-4369-A463-B1B730773755 Q36370851-FD9126CC-7B6C-47B7-A63A-CF54C6D13B99 Q36544872-B3DBF833-76CD-4EEB-86F5-1B30EA4E894F

P2860

The Notch/Hes1 pathway sustains NF-κB activation through CYLD repression in T cell leukemia.

http://www.wikidata.org/entity/Q34235332

description

2010 nî lūn-bûn

@nan

2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

The Notch/Hes1 pathway sustain ...... repression in T cell leukemia.

@ast

The Notch/Hes1 pathway sustain ...... repression in T cell leukemia.

@en

The Notch/Hes1 pathway sustain ...... repression in T cell leukemia.

@nl

type

label

The Notch/Hes1 pathway sustain ...... repression in T cell leukemia.

@ast

The Notch/Hes1 pathway sustain ...... repression in T cell leukemia.

@en

The Notch/Hes1 pathway sustain ...... repression in T cell leukemia.

@nl

prefLabel

The Notch/Hes1 pathway sustain ...... repression in T cell leukemia.

@ast

The Notch/Hes1 pathway sustain ...... repression in T cell leukemia.

@en

The Notch/Hes1 pathway sustain ...... repression in T cell leukemia.

@nl

P1433

Q34235332-D854FFC5-02F0-4154-B908-670B3D958F06

P1476

Q34235332-384EDD25-334D-4BEB-8307-EE160325F97B

P2093

Q34235332-03AC75EB-795D-461B-98F6-C668125B5E73

Q34235332-182913DC-4CE7-45CD-A136-A8608A0FCBCC

Q34235332-39D8E9BB-7F9B-4EE1-BF76-A07193760975

Q34235332-5AB02F51-A7CF-449B-A478-A5AD34C434FB

Q34235332-6D59CAE9-8D4E-4F2F-A66B-7FF3A5E8BCF0

Q34235332-802B1E88-D534-448A-A1A1-332035E0CC6B

Q34235332-88977DD4-64FD-4985-8611-233201C627F8

Q34235332-974CE700-BB7D-4675-A1C2-0341C6425504

Q34235332-9A9E0045-D767-4859-8483-4D3C18E3770F

Q34235332-A403457B-BA04-41D6-A6FA-EB56C059630F

P2860

Q34235332-01BCB6C5-8ED2-400A-83A5-79BD8458A8F8

Q34235332-03A0DED0-C504-4C41-B5F7-8269B28E4D57

Q34235332-0B991B5C-B65C-47A1-A492-41DC7937D36B

Q34235332-15281CE2-5C16-413D-8E18-6A741B4E31E4

Q34235332-1D8E9874-4F95-4101-A4CF-6878DCC03CF7

Q34235332-1DC10614-B515-4366-9B8E-CFE26F46546F

Q34235332-20E93061-43DA-41C9-BE42-376E9BA3869C

Q34235332-21520E8E-42FF-4E22-8E69-FDD6C8B5FA08

Q34235332-21BB397D-810F-42F7-9479-D08EBE3DA38A

Q34235332-26C0A4DF-9162-4E4C-97C5-FB516E34C056

P304

Q34235332-40921A84-6F62-45FB-A1F7-51FA4AEEB50D

P31

Q34235332-5D475928-9B40-4F26-833C-B42D52A54BA9

P356

Q34235332-2C4C668F-58E7-496A-9A3E-2905A4F11A27

P433

Q34235332-9AB27AA4-8D95-44C4-9A2A-FC97E332341A

P478

Q34235332-EBC76109-C830-4161-BD08-479A5DBD198E

P50

Q34235332-379E93D8-B89A-4F50-B88D-5D802B525B74

Q34235332-3CB98F88-C6BA-495F-B637-127AEA9F4D33

Q34235332-6C6C751D-8AB7-4E4F-9583-5D892542D409

Q34235332-7B47FB50-4EFA-426E-9D40-049CC8355F80

Q34235332-A13C12E0-C6EF-4A6F-9651-29D883216100

Q34235332-B42829AD-6EDC-4E2D-86A7-360A49F069F8

Q34235332-F6E07ECF-1134-4183-A1B7-B2B949E5F106

P577

Q34235332-81A907D2-19DD-4FA6-9585-D0810C900CEA

P5875

Q34235332-9122F1EB-8FC4-44C7-BF1D-5420245B14C7

P698

Q34235332-50E4B4AC-12FC-4068-B5BD-323F27569BFE

P921

Q34235332-77460EC8-44F3-486B-8151-52DFAE1A35C5

Q34235332-B67670EA-5207-44E8-BD85-766B04178708

P932

Q34235332-86E35433-67A0-471C-8348-66CCD71B99E8

P356

J.CCR.2010.08.006

P1433

P1476

The Notch/Hes1 pathway sustain ...... repression in T cell leukemia

@en

P2093

Alexander Statnikov

http://www.w3.org/2001/XMLSchema#string

Beatriz Bellosillo

http://www.w3.org/2001/XMLSchema#string

Carles Besses

http://www.w3.org/2001/XMLSchema#string

Charles C Mullighan

http://www.w3.org/2001/XMLSchema#string

Guangchan Song

http://www.w3.org/2001/XMLSchema#string

Iannis Aifantis

http://www.w3.org/2001/XMLSchema#string

Julia Inglés-Esteve

http://www.w3.org/2001/XMLSchema#string

Lluis Espinosa

http://www.w3.org/2001/XMLSchema#string

Nicole Kucine

http://www.w3.org/2001/XMLSchema#string

Ross L Levine

http://www.w3.org/2001/XMLSchema#string

P2860

The kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signalling pathway

Notch1 augments NF-kappaB activity by facilitating its nuclear retention

De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling

Notch1 and Notch2 inhibit myeloid differentiation in response to different cytokines.

IkappaBalpha and p65 regulate the cytoplasmic shuttling of nuclear corepressors: cross-talk between Notch and NFkappaB pathways

Identification of a conserved negative regulatory sequence that influences the leukemogenic activity of NOTCH1

Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex

Identification of the familial cylindromatosis tumour-suppressor gene

The Notch-Hes pathway in mammalian neural development

CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members

P304

268-281

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CCR.2010.08.006

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P50

Omar Abdel-Wahab

Anna Bigas Salvans

Verónica Rodilla

P577

2010-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

46219254

http://www.w3.org/2001/XMLSchema#string

P698

20832754

http://www.w3.org/2001/XMLSchema#string

P921

P932

2963042

http://www.w3.org/2001/XMLSchema#string